AKT1 and neuroblastoma: CBN, an agonist of CBRs with high affinity to CBR2 [33,34], remarkably increases CBR2 expression in SK-N-AS neuroblastoma cells, leading to inhibition of AKT pathway (Figure 2H), supporting a CBR2-dependent suppressive role of CBN in AKT signaling [35].